HEALTH CARE
- Share via
Marion Merrell, Lilly See Lower Earnings: Marion Merrell Dow Inc. said its per-share earnings in the first quarter will undershoot by as much as 70% Wall Street analyst’s estimates of 62 cents. The Kansas City firm, which reported earnings of 60 cents a share a year earlier, attributed the decline to sharply lower sales of the Seldane family of anti-allergy medications, the Nicoderm quit-smoking patch and Cardizem heart and blood medication. Indianapolis-based Eli Lilly & Co. said its first-quarter profit may fall nearly 20% to between $1.20 and $1.30 a share from $1.51 a year earlier. The company cited a mild flu season and other factors for the lower earnings.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.